Dengue fever cases dramatically decreased during the COVID-19 pandemic, but the tropical disease remains a threat to the Philippines, especially during the rainy season, with outbreaks always a possibility. “We need a vaccine for dengue,” Dr. Lulu Bravo, a vaccine expert, told INQUIRER.net in an online interview on Wednesday, the last day of June, which was National Dengue Awareness Month.
Takeda's tetravalent dengue vaccine (TAK-003) receives first global approval for use in Indonesia without need for pre-vaccination testing
Suspended dengue vaccine was given to 730,000 children
Why a universal dengue fever vaccine isn't available, explained - Vox
Targets and strategies for vaccine development against dengue viruses - ScienceDirect
Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults
Philippines Halts Major Dengue Vaccination Program Because Vaccine May Increase Risk of Severe Disease
Frontiers Challenges in Dengue Vaccines Development: Pre-existing Infections and Cross-Reactivity
F.D.A. Approves the First Vaccine for Dengue Fever, but Limits Its
Dengue: Practice Essentials, Background, Pathophysiology
Philippines - Traveler view, Travelers' Health
PH needs vaccine for dengue as disease remains a threat despite
Safety Concerns About Dengue Vaccine Shut Down Immunization
CDC in Philippines, Global Health
Vaccine case study: Exploring the controversy around Dengvaxia and vaccine misinformation in the Philippines - First Draft
Measles and the Threat of the Anti-vaccination Movement